Bedrijfsupdate14 okt 2026ENLakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell TherapeuticsLakefront Biotherapeutics NVCompany newsroom
Bedrijfsupdate8 okt 2026ENLakefront Receives Transparency Notification from Bank of AmericaLakefront Biotherapeutics NVCompany newsroom
Bedrijfsupdate8 sep 2026ENLakefront to Present at the Morgan Stanley 24th Annual Global Healthcare ConferenceLakefront Biotherapeutics NVCompany newsroom
Bedrijfsupdate24 aug 2026ENU.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of PemphigusLakefront Biotherapeutics NVCompany newsroom
Bedrijfsupdate24 aug 2026ENLakefront Receives Transparency Notification from Bank of AmericaLakefront Biotherapeutics NVCompany newsroom
Bedrijfsupdate10 aug 2026ENLakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business UpdateLakefront Biotherapeutics NVCompany newsroom
